With 1 in 3 nurses suffering from hand dermatitis, Ansell has launched a new allergy campaign to spread the word among health practitioners about allergies in the workplace, specifically Type IV chemical allergies. The new campaign is designed to both educate and entertain by voicing the Type IV allergy story though a beloved genre sure to resonate with all audiences -- the fairy tale.
A whimsical and interactive microsite, online banners and magazine ads give healthcare practitioners the opportunity to learn how to recognize and avoid the painful effects of Type IV allergies in an engaging format. Those who participate in the contest on the microsite have the opportunity to create their own fairy tale ending and possibly win a $1,000 Disney gift card, which can be used for a magical Disney adventure. The promotion runs from Sept. 27, 2012 through March 8, 2013Â at www.ansellprotects.com/happyeverafter/. See full official rules for the promotion at www.ansellprotects.com/happyeverafter/.
Allergic reactions can be debilitating causing occupational, physical, and even emotional issues, says Bob Gaither, senior vice president and regional director at Ansell, North America. We wanted to tell the allergy story in a way that engages, entertains and rewards the audience to help them better process this important information and increase the likelihood that they will share it with their peers who might otherwise not understand the source of their pain, said Gaither. By facilitating an ongoing conversation around Type IV allergies in the healthcare industry, we hope to promote education and knowledge to help put an end to the suffering. The Disney prize is another way to show our immense appreciation for all that these tireless healthcare practitioners do.
Source: Ansell Limited
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
COVID-19 Realities: Beyond a Respiratory Virus, Addressing Optimism in Pandemic Management
February 28th 2024A recent commentary by Dr. Amesh Adalja in MedPage Today challenges the perception of COVID-19 as solely a respiratory virus, highlighting its broader impact on the body. This analysis questions the notion that COVID-19 should be managed like common respiratory infections, urging a closer look at vaccine effectiveness, the rise of long COVID, and the need for enhanced measures to curb the virus's spread. Let's explore the complexities of COVID-19 management and the pressing realities faced by the US and the world.
The Neglected Tropical Diseases You’ve Never Heard Of
February 27th 2024The 20 conditions, known as neglected tropical diseases (NTDs), are estimated to affect more than 1 billion people, yet many individuals have never heard of them. Heather Saunders, MPH, RN, CIC, discusses 5 of them and what is being done to prevent their spread.